Charu Aggarwal
Showed that adding blood-based sequencing to tissue testing finds more targetable lung cancer mutations.
Thoracic oncologist whose plasma-NGS studies changed how metastatic lung cancer is genotyped; leads immunotherapy and head-and-neck trials at Penn.
| Title | Journal | Year |
|---|---|---|
| Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer | JAMA Oncology | 2019 |
Pages like this
not linked directly; found by shared links- InstitutionHealthCare Global Enterprises
Shares Comprehensive genomic profiling, Liquid biopsy (ctDNA), Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- InstitutionQueen Mary Hospital / University of Hong Kong
Shares Liquid biopsy (ctDNA), Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- PersonNathan A. Pennell
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- PersonNatasha B. Leighl
- InstitutionRajiv Gandhi Cancer Institute and Research Centre
Shares Comprehensive genomic profiling, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- PersonLillian L. Siu
Shares Liquid biopsy (ctDNA), Head and neck squamous cell carcinoma.
- PersonChristophe Le Tourneau
Shares Comprehensive genomic profiling, Head and neck squamous cell carcinoma.
- PersonDaniel A. Haber